New strategies for peritoneal dialysis fluids

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 1, 1997, Pages 74-77

  Gokal, R ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CALCIUM ION; DEXTRIN; GLUCOSE POLYMER; GLYCOSYLATED PROTEIN; LACTIC ACID; OSMOTIC AGENT; PERITONEAL DIALYSIS FLUID; SODIUM ION;

CONFERENCE PAPER; PERITONEAL DIALYSIS; PH; PRIORITY JOURNAL;

DIALYSIS SOLUTIONS; HUMANS; KIDNEY DISEASES; PERITONEAL DIALYSIS;

EID: 0031052202     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Gokal R. Peritoneal dialysis. In: Camerson S et al., eds, Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, 1992; 1477-1505
2. Holmes CJ. Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13: 88-94
3. Dobbie J. Durability of the peritoneal membrane. Perit Dial Int 1995; 15(suppl): 587-594
4. Breborowicz A, Oreopulos D. Physiological approaches to increase biocompatibility of peritoneal dialysis. Perit Dial Int 1995; 15(7, suppl): S76-S86
5. Faller B, Marichal JF. Loss of ultrafiltration in CAPD: a role for acetate. Perit Dial Bull 1984; 4: 10-13
6. Yasuda T, Ozawa S, Sheba C et al. D-Lactate metabolism in patients with chronic renal failure undergoing CAPD. Nephron 1993; 63: 416-422
7. Brunkhorst R, Mahiout A. Pyruate as non toxic peritoneal dialysate buffer; maintained mesothelial cell integrity and proliferation. J Am Soc Nephrol 1994; 5: 410
8. Feriani M, Biasioli S, Borin D et al. Bicarbonate solutions for peritoneal dialysis: a reality. Int J Artif Organs 1985; 8: 57-58
9. Feriani M, Passlich Deetjen J, LaGreca G. Factors affecting bicarbonate transfer with bicarbonate containing CAPD solution. Peril Dial Int 1995; 15(7, suppl): S336-S341
10. Yatzides H. New stable bicarbonate solution for peritoneal dialysis: preliminary report. Perit Dial Int 1991; 11: 224-227
11. Slingeneyer A, Faller B, Michel C, Przbylske C. Rolland R, Mion C. Increased ultrafiltration capacity using a new bicarbonate CAPD solution. Perit Dial Int 1993; 13: 57
12. Liberek T, Topley N, Jorres A, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of phagocyte function: effect of osmolality and glucose concentrations. J Am Soc Nephrol 1993; 3: 1508-1515
13. Topley M, Mackenzie R, Peterson M et al. In vitro testing of potentially biocompatible CAPD fluids. Nephrol Dial Transplant 1991; 6: 574-581
14. Hjelle JT, Miller-Hyelle MA, Dobbie J. The biology of the mesothelium during peritoneal dialysis. Perit Dial Int 1995; 15(7, suppl): S13-S28
15. Mahiout A, Erlerding G, Krautizig S, Brunkhorst R. Production of advanced glycosulation end products (AGE) in the peritoneum of CAPD patients. J Am Soc Nephrol 1994; 5: 464
16. Kopple J, Bernard D, Messana J et al. Treatment of malnourished CAPD patients with amino acid based dialysate. Kidney Int 1995; 47: 448-457
17. Mistry CD, Mallick NP, Gokal R. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; ii: 178-182
18. Mistry CD, Gokal R, Peers EM, MIDAS Study Group. A randomised multicentre clinical trial comparing isosmolar icodextrin with hyperosmolar glucose in CAPD. Kidney Int 1994; 46: 496-503
19. Stein A, Peers E, Hattersley J et al. Clinical experience with icodextrin in CAPD patients. Perit Dial Int 1994; 14(Suppl 2): S51-S54
20. Posthuma N, Wee P, Doinker A, Oe RP, Verbrugh HA, Peers E. Improved ultrafiltration in CCPD patients using icodextrin instead of glucose during the long daytime dwell. J Am Soc Nephrol 1995; 6: 513
21. Gokal R, Mistry C, Peers E and Midas Study Group. Peritonitis occurrence in a multicentre study of Icodextrin and glucose in CAPD. Perit Dial Int 1995; 15: 226-230
22. Flessner MF. Osmotic barrier of the parietal peritoneum. Am J Physiol 1994; 267: F861-F870
23. Lamb E, Cattell W, Dawnay A. Glycated albumen in serum and dialysate of patients in CAPD. Clin Sci 1993; 84: 619-626
24. Yamada K, Miyakasa Y, Hamaguchi K et al. Immunohistochemical study of human advanced glycosylation end products (AGE) in chronic renal failure. Clin Nephrol 1994; 42: 354-361
25. Millar DJ, Dawnay A. Glycation of albumin with icodextrin. J Am Soc Nephrol 1995; 6: 551
26. Faller B, Shcokley T, Genestier S et al. A comparative clinical study of peritoneal dialysis solutions containing polyglucose in combination with amino acids. J Am Soc Nephrol 1995; 6: 510
27. Imholz ALT, Koomen G, Struijk D, Arisz L, Krediet R. Fluid and solute transplant in CAPD using ultralow sodium dialysate. Kidney Int 1994; 46: 333-340
28. Nakayama M, Kawaguchi Y, Yokoyama K et al. Anti hypertensive effect of low sodium concentration (120 mEg/1) solution for CAPD patients. Clin Nephrol 1994; 41: 357-363
29. 3. Perit Dial Int 1989; 9: 325-328
30. Hutchison A, Freemont AJ, Boulton HF, Gokal R. Low calcium dialysis fluid and oral calcium carbonate in CAPD: a method of controlling hyperphopshataemia whilst minimising aluminium exposure and hypercalcaemia. Nephrol Dial Transplant 1992; 7: 1219-1225
31. Weinreich T, Passlich-Deetjen J, Ritz E and collaboration of PD Multicentre Study. Am J Kidney Dis 1995; 25: 452-460
32. Cunningham J, Beer J, Coldwell RD, Noonn K, Sawyer N, Makin H. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. Nephrol Dial Transplant 1992; 7: 63-68
33. Weinreich T, Ritz E, Parslick-Deetjen J. Long term dialysis with low calcium solution in CAPD - effects bone mineral metabolism. Perit Dial Int 1996; in press
34. Hutchison A, Turner K, Gokal R. Effect of long term therapy with 1.25 mmol/1 calcium PD fluid on incidence of peritonitis in CAPD. Perit Dial Int 1992; 12: 321-325
35. Gotloib L, Shostach A, BarSella P et al. Continuous mesothelial injury and regeneration during long term peritoneal dialysis. Perit Dial Bull 1987; 7: 148-155
36. Lipkin GW, Forbes MA, Cooper EH et al. Hyaluronic acid metabolism and its clinical significance in patients treated by CARD. Nephrol Dial Transplant 1993; 8: 357-360
37. Wieczorowska K, Breborowcz A, Martis L et al. Protective effect of hyaluronic acid against peritoneal injury. Peril Dial Int 1995; 15: 81-83
38. Bazzato G, Fracasso A, Gambaro G, Baggio B. Use of glycosaminoglycons to increase efficiency of long term continuous peritoneal dialysis. Lancet 1995; 346: 740-741
39. DiPaolo N, Vanni L, Sacchi G. Autologous implant of peritoneal mesothelium in rabbits and man. Clin Nephrol 1990; 34: 179-184